synchronous bilateral breast cancer

Release time ：Dec-19,2024

Synchronous bilateral breast cancer describes the occurrence of malignant tumors in both breasts simultaneously, a relatively uncommon condition that poses significant challenges to patient management and prognosis once diagnosed.

The prevalence of synchronous bilateral breast cancer is low, constituting approximately 5% to 10% of all breast cancer cases. Typically, patients are found to have abnormal nodules in both breasts during routine examinations or breast cancer screenings. The tumors on each side may share the same pathological type and molecular subtype, or they may differ. Treatment strategies must take into account the characteristics of both tumors, encompassing surgical options (which could include bilateral mastectomy), radiation therapy, chemotherapy, and targeted therapies. The risks and side effects associated with surgery and radiation therapy may be heightened due to the bilateral involvement, while chemotherapy and targeted therapy choices may be guided by the molecular profile of the tumors.

Early diagnosis and a comprehensive, multidisciplinary approach to treatment are essential for patients with synchronous bilateral breast cancer. It is imperative that patients develop a personalized treatment plan under the direction of specialized physicians, closely monitor their physical responses to treatment, and adjust strategies as needed. Additionally, the psychological well-being of the patient is crucial, and support from family and society can greatly assist patients in coping with the stress and challenges associated with the disease.

In conclusion, synchronous bilateral breast cancer, though rare, has a profound impact on patients. It is vital for patients to actively engage in their treatment regimens and maintain a positive attitude to enhance treatment outcomes and overall quality of life.